233 related articles for article (PubMed ID: 26005872)
21. Impact of hyperuricemia and chronic kidney disease on the prevalence and mortality of cardiovascular disease in cancer survivors.
Chen Y; Chen Y; Lin W; Fu L; Liu H; Pu S; Chen H; Yi H; Xue Y
Cancer Med; 2024 May; 13(9):e7180. PubMed ID: 38686569
[TBL] [Abstract][Full Text] [Related]
22. Plasma Xanthine Oxidase Activity Is Predictive of Cardiovascular Disease in Patients with Chronic Kidney Disease, Independently of Uric Acid Levels.
Gondouin B; Jourde-Chiche N; Sallee M; Dou L; Cerini C; Loundou A; Morange S; Berland Y; Burtey S; Brunet P; Guieu R; Dussol B
Nephron; 2015; 131(3):167-74. PubMed ID: 26426087
[TBL] [Abstract][Full Text] [Related]
23. Chronic hyperuricemia, uric acid deposit and cardiovascular risk.
Grassi D; Ferri L; Desideri G; Di Giosia P; Cheli P; Del Pinto R; Properzi G; Ferri C
Curr Pharm Des; 2013; 19(13):2432-8. PubMed ID: 23173592
[TBL] [Abstract][Full Text] [Related]
24. [Hyperuricemia and cardiovascular diseases: from phylogenesys to patogenetic mechanisms].
Trepiccione F; Perna AF
G Ital Nefrol; 2015; 32 Suppl 62():. PubMed ID: 26005870
[TBL] [Abstract][Full Text] [Related]
25. Hyperuricemia in Kidney Disease: A Major Risk Factor for Cardiovascular Events, Vascular Calcification, and Renal Damage.
Ejaz AA; Nakagawa T; Kanbay M; Kuwabara M; Kumar A; Garcia Arroyo FE; Roncal-Jimenez C; Sasai F; Kang DH; Jensen T; Hernando AA; Rodriguez-Iturbe B; Garcia G; Tolan DR; Sanchez-Lozada LG; Lanaspa MA; Johnson RJ
Semin Nephrol; 2020 Nov; 40(6):574-585. PubMed ID: 33678312
[TBL] [Abstract][Full Text] [Related]
26. Is there anything good in uric acid?
Alvarez-Lario B; Macarrón-Vicente J
QJM; 2011 Dec; 104(12):1015-24. PubMed ID: 21908382
[TBL] [Abstract][Full Text] [Related]
27. Does asymptomatic hyperuricaemia contribute to the development of renal and cardiovascular disease? An old controversy renewed.
Kanellis J; Feig DI; Johnson RJ
Nephrology (Carlton); 2004 Dec; 9(6):394-9. PubMed ID: 15663643
[TBL] [Abstract][Full Text] [Related]
28. The role of hyperuricemia in vascular disorders.
Edwards NL
Curr Opin Rheumatol; 2009 Mar; 21(2):132-7. PubMed ID: 19339923
[TBL] [Abstract][Full Text] [Related]
29. Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease?
Johnson RJ; Kang DH; Feig D; Kivlighn S; Kanellis J; Watanabe S; Tuttle KR; Rodriguez-Iturbe B; Herrera-Acosta J; Mazzali M
Hypertension; 2003 Jun; 41(6):1183-90. PubMed ID: 12707287
[TBL] [Abstract][Full Text] [Related]
30. Uric acid and transplantation.
Mazali FC; Mazzali M
Semin Nephrol; 2011 Sep; 31(5):466-71. PubMed ID: 22000655
[TBL] [Abstract][Full Text] [Related]
31. Uric acid and chronic renal disease: possible implication of hyperuricemia on progression of renal disease.
Kang DH; Nakagawa T
Semin Nephrol; 2005 Jan; 25(1):43-9. PubMed ID: 15660334
[TBL] [Abstract][Full Text] [Related]
32. Serum uric acid levels in kidney transplant recipients: A cause for concern? A review of recent literature.
Imasuen UJ; Swanson KJ; Parajuli S
Transplant Rev (Orlando); 2023 Jul; 37(3):100775. PubMed ID: 37437509
[TBL] [Abstract][Full Text] [Related]
33. Uric acid--a uremic toxin?
Nakagawa T; Mazzali M; Kang DH; Sánchez-Lozada LG; Herrera-Acosta J; Johnson RJ
Blood Purif; 2006; 24(1):67-70. PubMed ID: 16361844
[TBL] [Abstract][Full Text] [Related]
34. Uric Acid, Vascular Stiffness, and Chronic Kidney Disease: Is There a Link?
Ramirez-Sandoval JC; Sanchez-Lozada LG; Madero M
Blood Purif; 2017; 43(1-3):189-195. PubMed ID: 28114139
[TBL] [Abstract][Full Text] [Related]
35. Allopurinol and progression of CKD and cardiovascular events: long-term follow-up of a randomized clinical trial.
Goicoechea M; Garcia de Vinuesa S; Verdalles U; Verde E; Macias N; Santos A; Pérez de Jose A; Cedeño S; Linares T; Luño J
Am J Kidney Dis; 2015 Apr; 65(4):543-9. PubMed ID: 25595565
[TBL] [Abstract][Full Text] [Related]
36. [HYPERURICEMIA AND POTENTIAL RISK OF CARDIOVASCULAR AND RENAL DISEASES].
Schils R; Krzesinski JM
Rev Med Liege; 2016 May; 71(5):262-8. PubMed ID: 27337847
[TBL] [Abstract][Full Text] [Related]
37. Hyperuricemia, the heart, and the kidneys - to treat or not to treat?
Petreski T; Ekart R; Hojs R; Bevc S
Ren Fail; 2020 Nov; 42(1):978-986. PubMed ID: 32972284
[TBL] [Abstract][Full Text] [Related]
38. J-shaped mortality relationship for uric acid in CKD.
Suliman ME; Johnson RJ; García-López E; Qureshi AR; Molinaei H; Carrero JJ; Heimbürger O; Bárány P; Axelsson J; Lindholm B; Stenvinkel P
Am J Kidney Dis; 2006 Nov; 48(5):761-71. PubMed ID: 17059995
[TBL] [Abstract][Full Text] [Related]
39. What is the effect on cardiovascular events of reducing hyperuricemia with allopurinol? An evidence-based review.
Guedes M; Esperança A; Pereira AC; Rego C
Rev Port Cardiol; 2014 Nov; 33(11):727-32. PubMed ID: 25444231
[TBL] [Abstract][Full Text] [Related]
40. Uric acid as a cardiorenal mediator: pathogenesis and mechanistic insights.
Gulab A; Torres R; Pelayo J; Lo KB; Shahzad A; Pradhan S; Rangaswami J
Expert Rev Cardiovasc Ther; 2021 Jun; 19(6):547-556. PubMed ID: 34112023
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
